Golden Angels Investors

Type

Angel Group/Syndicate

Status

Active

Location

Brookfield, United States

Total investments

51

Average round size

2M

Portfolio companies

33

Rounds per year

2.32

Lead investments

4

Follow on index

0.35

Exits

5

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareMobileHealth CareEdTechEducationMedicalHealth InsuranceInsurancePharmaceutical

Summary

In 2002 was created Golden Angels Investors, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Brookfield.

The current fund was established by Tim Keane. Besides them, we counted 1 critical employee of this fund in our database.

The high activity for fund was in 2014. When the investment is from Golden Angels Investors the average startup value is 5-10 millions dollars. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 1 - 5 millions dollars. Comparing to the other companies, this Golden Angels Investors performs on 18 percentage points less the average number of lead investments. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2019.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Internet, Medical Device. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Promentis Pharmaceuticals, Codaworx, Page Vault.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Golden Angels Investors, startups are often financed by WomensVCFund, Wisconsin Investment Partners, Steve Blank. The meaningful sponsors for the fund in investment in the same round are Wisconsin Investment Partners, BrightStar Wisconsin Foundation, Inventure Capital, Madison. In the next rounds fund is usually obtained by Wisconsin Investment Partners, F-Prime Capital, Elemental Excelerator.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
51
Lead investments
4
Exits
5
Rounds per year
2.32
Follow on index
0.35
Investments by industry
  • Software (15)
  • Biotechnology (13)
  • Medical (10)
  • Health Care (8)
  • EdTech (6)
  • Show 79 more
Investments by region
  • United States (50)
  • Canada (1)
Peak activity year
2014

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
766K
Group Appearance index
0.65
Avg. company exit year
7

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Abre.io 11 Apr 2024 Software, Education Early Stage Venture 24M United States, Ohio, Cincinnati
Immuto Scientific 08 Oct 2021 Biotechnology, Pharmaceutical Seed 2M United States, Wisconsin, Madison
MK Biotech 17 Jan 2020 Biotechnology, Medical, Pharmaceutical Early Stage Venture 4M Taejon-jikhalsi, Daejeon, South Korea

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.